GlassScriptPhysician profile
Brian A Seeck
NPI 1689714289
$10,443.10
in general payments reported to CMS, 2019-2025
51 companies · $1,426 in 2025
The $1,426 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $741 · 2021: $1,163 · 2022: $1,501 · 2023: $3,149 · 2024: $1,487 · 2025: $1,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,999 · Travel and Lodging: $1,030 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,999.46 |
| Travel and Lodging | $1,030.40 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,959.65 | 2021-2025 | Amplia Mri Quad Crt-D Surescan, Micra, Attain Command + Surevalve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $879.11 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $762.89 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $619.94 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $572.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic Vascular, INC. | $493.27 | 2019-2020 | |
| Boston Scientific Corporation | $459.29 | 2021-2025 | General - Therapies, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $456.16 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $415.27 | 2019-2025 | |
| Abbott Laboratories | $281.53 | 2019-2025 | Jeti Peripheral Catheter, Cardiomems, Jeti |
| Kestra Medical Technology Services, INC. | $254.48 | 2023-2025 | Assure Wcd |
| Cvrx, INC. | $247.09 | 2022-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $174.42 | 2020-2025 | Camzyos, Eliquis |
| Lilly USA, LLC | $155.35 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| W. L. Gore & Associates, INC. | $154.38 | 2021-2024 | C3 Delivery System |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Seeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.